AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- EBITDA, 2025
- −$166M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$166M | — |
| 2024 | −$280M | — |
| 2023 | −$231M | — |
| 2022 | −$180M | — |
| 2021 | −$125M | — |
| 2020 | −$99M | — |
| 2019 | −$67M | — |
| 2018 | −$33M | — |
| 2017 | −$27M | — |
| 2016 | −$28M | — |
| 2015 | −$9.2M | — |